Clinical Trial Update: Efficacy of MR-HIFU Ablation of Breast Cancer [NA]

View source ↗

Summary

A clinical trial evaluating MR-HIFU ablation for breast cancer has been withdrawn (NCT02407613; sponsor UMC Utrecht; status: withdrawn).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UMC Utrecht | Conditions: Breast Cancer | NA | Status: WITHDRAWN